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Thank you for your thoughtful comments and for taking
time to read our paper. We agree that we should have been
more explicit about distinguishing DTC advertising from
testing when mentioning the Myriad BRCA testing adver-
tisement campaign. We also agree that it is possible that
some people could have responded affirmatively to the
survey question about DTC test awareness when it was
really DTC advertising that they were aware of. The HINTS
2007 question was worded as, “Genetic tests that analyze
your DNA, diet, and lifestyle for potential health risks are
currently being marketed by companies directly to consum-
ers. Have you heard or read about these genetic tests?” As
with any secondary data analysis, we cannot assess how
respondents interpreted the question, nor can we distinguish
how they specifically became aware of DTC genetic tests
(e.g., from DTC advertising, healthcare providers, websites,
family members or friends).
The goal of our study was not to estimate true awareness
of DTC tests with high level precision but rather to look at
racial/ethnic group differences on a DTC genetic test aware-
ness item, while also evaluating numeracy correlates. As
with all self-report items like those used in HINTS 2007,
there is some level of measurement error. While such errors
likely affect the accuracy of our estimates of the overall
prevalence of consumer awareness of DTC genetic testing
products, we find it difficult to see how this issue would
materially change the interaction with numeracy that is the
core of our research findings.
We note in our paper that there is no consensus in the
field on the best way to present health information in the
context of genetic tests (both DTC and clinical included).
We also outline several areas of potential research such as
communications training, different ways to present numb-
ers, and screening tools to assess patient preferences for
health information. More research in these areas may help
support informed decision making among consumers and
equip genetic counselors with better tools to use with
patients.
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